In terms of breast cancer classification, all subtypes of breast cancer exhibit lower SLC7A3 expression compared to normal breast tissue, especially TNBC and HER2-positive breast cancer, which are aggressive breast cancers. Here, SLC7A3 is linked to breast cancer.